paracelsus

The name parazelsus is derived from Swiss doctor and alchemist Philippus Theophrastus Aureolus Bombastus von Hohenheim (1493–1541), who took the name Paracelsus later in life. He referred to Celsus, an earlier roman physician, but meant to move medicine beyond his times. Paracelsus introduced the treatment of illnesses with chemical substances during the Renaissance period. Many early advances in modern medicine are based on the research and work performed by Paracelsus.

Parazelsus Group is an independent, pro-active investment and management group, founded by Peter Zuellig in 2005. The team at Parazelsus includes industry and financial experts for its key investment areas – not alchemists. However, parazelsus understands very well how to generate value in the healthcare sector through an unconventional approach.